268 related articles for article (PubMed ID: 36899406)
1. The diagnostic value of contrast-enhanced ultrasonography in breast ductal abnormalities.
Wang B; Yang D; Zhang X; Gong X; Xu T; Han J; Ren Y; Zou S; Li L; Wang Y
Cancer Imaging; 2023 Mar; 23(1):25. PubMed ID: 36899406
[TBL] [Abstract][Full Text] [Related]
2. Breast non-mass-like lesions on contrast-enhanced ultrasonography: Feature analysis, breast image reporting and data system classification assessment.
Xu P; Yang M; Liu Y; Li YP; Zhang H; Shao GR
World J Clin Cases; 2020 Feb; 8(4):700-712. PubMed ID: 32149054
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of contrast-enhanced ultrasonography and ultrasound elastography for management of BI-RADS category 4 nonpalpable breast masses.
Niu Q; Zhao L; Wang R; Du L; Shi Q; Jia C; Li G; Jin L; Li F
Eur J Radiol; 2024 Apr; 173():111391. PubMed ID: 38422608
[TBL] [Abstract][Full Text] [Related]
4. The role of contrast-enhanced ultrasound in the diagnosis of malignant non-mass breast lesions and exploration of diagnostic criteria.
Zhang F; Jin L; Li G; Jia C; Shi Q; Du L; Wu R
Br J Radiol; 2021 Apr; 94(1120):20200880. PubMed ID: 33560894
[TBL] [Abstract][Full Text] [Related]
5. Application of Contrast-Enhanced Ultrasound in the Diagnosis of Ductal Carcinoma In Situ: Analysis of 127 Cases.
Li W; Zhou Q; Xia S; Wu Y; Fei X; Wang Y; Tao L; Fan J; Zhou W
J Ultrasound Med; 2020 Jan; 39(1):39-50. PubMed ID: 31206200
[TBL] [Abstract][Full Text] [Related]
6. Papillary breast lesions on contrast-enhanced ultrasound: morphological enhancement patterns and diagnostic strategy.
Xia HS; Wang X; Ding H; Wen JX; Fan PL; Wang WP
Eur Radiol; 2014 Dec; 24(12):3178-90. PubMed ID: 25149297
[TBL] [Abstract][Full Text] [Related]
7. The value of contrast-enhanced ultrasound in the diagnosis of BI-RADS-US 4a lesions less than 2 cm in diameter.
Yu MQ; Zhang LL; Jiang LP; Zhou AY
Clin Hemorheol Microcirc; 2023; 83(3):195-205. PubMed ID: 35599475
[TBL] [Abstract][Full Text] [Related]
8. Application of contrast-enhanced ultrasound in the diagnosis of small breast lesions.
Du YR; Wu Y; Chen M; Gu XG
Clin Hemorheol Microcirc; 2018; 70(3):291-300. PubMed ID: 29710688
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of contrast-enhanced ultrasound of breast BI-RADS 3-5 lesions.
Janu E; Krikavova L; Little J; Dvorak K; Brancikova D; Jandakova E; Pavlik T; Kovalcikova P; Kazda T; Valek V
BMC Med Imaging; 2020 Jun; 20(1):66. PubMed ID: 32552678
[TBL] [Abstract][Full Text] [Related]
10. The kinetic quantitative characteristics of non-mass breast lesions with contrast-enhanced ultrasound: a prospective study.
Cai YY; Du YC; Zhao L; Hu WJ; Bai Y; Chen A; Du LF; Li F
Br J Radiol; 2023 Dec; 96(1152):20221002. PubMed ID: 37660395
[TBL] [Abstract][Full Text] [Related]
11. Clinical diagnostic value of contrast-enhanced ultrasound and TI-RADS classification for benign and malignant thyroid tumors: One comparative cohort study.
Xu Y; Qi X; Zhao X; Ren W; Ding W
Medicine (Baltimore); 2019 Jan; 98(4):e14051. PubMed ID: 30681562
[TBL] [Abstract][Full Text] [Related]
12. A Prospective Study on the Value of Ultrasound Microflow Assessment to Distinguish Malignant from Benign Solid Breast Masses: Association between Ultrasound Parameters and Histologic Microvessel Densities.
Park AY; Kwon M; Woo OH; Cho KR; Park EK; Cha SH; Song SE; Lee JH; Cha J; Son GS; Seo BK
Korean J Radiol; 2019 May; 20(5):759-772. PubMed ID: 30993927
[TBL] [Abstract][Full Text] [Related]
13. Value of contrast-enhanced malignancy imaging features in secondary grade diagnosis of BI-RADS-US type 4 breast lesions.
Gao J; Han W; Ai Si Mu Tu La DLMT; Hou X; Li ZM; Song T
Tumori; 2021 Oct; 107(5):424-431. PubMed ID: 33124515
[TBL] [Abstract][Full Text] [Related]
14. Differentiating benign from malignant solid breast lesions: combined utility of conventional ultrasound and contrast-enhanced ultrasound in comparison with magnetic resonance imaging.
Du J; Wang L; Wan CF; Hua J; Fang H; Chen J; Li FH
Eur J Radiol; 2012 Dec; 81(12):3890-9. PubMed ID: 23062280
[TBL] [Abstract][Full Text] [Related]
15. Papillary breast lesions detected using conventional ultrasound and contrast-enhanced ultrasound: Imaging characteristics and associations with malignancy.
Niu RL; Li SY; Wang B; Jiang Y; Liu G; Wang ZL
Eur J Radiol; 2021 Aug; 141():109788. PubMed ID: 34091133
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Value of Conventional Ultrasonography Combined with Contrast-Enhanced Ultrasonography in Thyroid Imaging Reporting and Data System (TI-RADS) 3 and 4 Thyroid Micronodules.
Liu Y; Wu H; Zhou Q; Gou J; Xu J; Liu Y; Chen Q
Med Sci Monit; 2016 Aug; 22():3086-94. PubMed ID: 27580248
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced ultrasonographic findings of different histopathologic types of breast cancer.
Wang X; Xu P; Wang Y; Grant EG
Acta Radiol; 2011 Apr; 52(3):248-55. PubMed ID: 21498359
[TBL] [Abstract][Full Text] [Related]
18. The discriminatory diagnostic value of multimodal ultrasound combined with blood cell analysis for granulomatous lobular mastitis and invasive ductal carcinoma of the breast.
Zeng YH; Yang YP; Liu LJ; Xie J; Dai HX; Zhou HL; Huang X; Huang RL; Liu EQ; Deng YJ; Li HJ; Wu JJ; Zhang GL; Liao ML; Xu XH
Clin Hemorheol Microcirc; 2024; 86(4):481-493. PubMed ID: 38007642
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of sub-centimetre breast lesions: combining BI-RADS-US with strain elastography and contrast-enhanced ultrasound-a preliminary study in China.
Xiao X; Jiang Q; Wu H; Guan X; Qin W; Luo B
Eur Radiol; 2017 Jun; 27(6):2443-2450. PubMed ID: 27761708
[TBL] [Abstract][Full Text] [Related]
20. Comparison of microvascular flow imaging and contrast-enhanced ultrasound for blood flow analysis of cervical lymph node lesions.
Wang T; Xu M; Xu C; Wu Y; Dong X
Clin Hemorheol Microcirc; 2023; 85(3):249-259. PubMed ID: 37694358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
